Acción 6499 MEDEON BIODESIGN, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Medeon Biodesign, Inc.

Acciones

6499

TW0006499007

Precio de cierre Taipei Exchange
Otros sitios de cotización
 00:00:00 08/05/2024 		Varia. Cinco días. Varia. 1 de enero.
42,9 TWD +0,94 % Gráfico intradía de Medeon Biodesign, Inc. +1,06 % -8,04 %
08/03 Medeon Biodesign, Inc. informa de los resultados del ejercicio finalizado el 31 de diciembre de 2023 CI
2023 Medeon Biodesign, Inc. informa de los resultados del tercer trimestre y los nueve meses finalizados el 30 de septiembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Medeologix Inc. announced that it expects to receive TWD 315 million in funding from Medeon Biodesign, Inc.
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Medeon Biodesign, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Medeon Biodesign, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Medeon Biodesign, Inc.(TPEX:6499) added to S&P Global BMI Index
Medeon Biodesign, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Medeon Biodesign, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Medeon Biodesign, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
Medeon Announces Positive Clinical Results for XFLO Minimally Invasive BPH Treatment Device
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
Medeon Biodesign, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020
Medeon Biodesign, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 6499
  4. Noticias Medeon Biodesign, Inc.
  5. Otros idiomas